Recombinant Mouse TDO2 His-tag Protein, CF

R&D Systems | Catalog # 10001-TD

R&D Systems
100% Guarantee

Key Product Details

  • R&D Systems E. coli-derived Recombinant Mouse TDO2 His-tag Protein (10001-TD)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

E. coli

Accession Number

P48776

Applications

Enzyme Activity
View all TDO2 Proteins and Enzymes »

Product Specifications

Source

E. coli-derived mouse TDO2 protein
Val18-Phe388
with a C terminal 6-His tag

Purity

>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Val18

Predicted Molecular Mass

45 kDa

SDS-PAGE

39 & 75 kDa, reducing conditions

Activity

Measured by its ability to oxidize L-tryptophan to N-formyl-kynurenine.
The specific activity is >500 pmol/min/μg, as measured under the described conditions.

Scientific Data Images for Recombinant Mouse TDO2 His-tag Protein, CF

Recombinant Mouse TDO2 His-tag Protein Enzyme Activity

Recombinant Mouse TDO2 His-tag Protein Enzyme Activity

Recombinant Mouse TDO2 (Catalog # 10001-TD) is measured by its ability to oxidize L-tryptophan to N-formyl-kynurenine.
Recombinant Mouse TDO2 His-tag Protein SDS-PAGE

Recombinant Mouse TDO2 His-tag Protein SDS-PAGE

1 μg/lane of Recombinant Mouse TDO2 was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by silver staining, showing bands at 39 kDa and 75 kDa under R conditions.

Formulation, Preparation, and Storage

10001-TD
Formulation Supplied as a 0.2 μm filtered solution in Tris, NaCl and Glycerol.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: TDO2

Tryptophan 2,3-dioxygenase (TDO2), a heme-containing cytosolic dioxygenase, forms a homo-tetrameric active molecule of approximately 190 kDa composed of 48 kDa monomers (1, 2). Mouse TDO2 shares 89% aa sequence identity with human TDO2. TDO2 is one of three proteins capable of catalyzing the first and rate-limiting step of the L-kynurenine pathway (KP): oxidative cleavage of the essential amino acid L-tryptophan to form N formyl kynurenine (3). TDO2 is a cytosolic protein typically localized to the liver and brain, unlike the more ubiquitously expressed indoleamine 2,3-dioxygenase (IDO), yet it is responsible for ~90% of the primary route of catabolism of tryptophan through the KP (3). TDO2 is upregulated in extrahepatic tumors (4-6) and is consequently a target in cancer immunotherapy (7). TDO2 is a therapeutic target in brain disease such as schizophrenia, Alzheimers disease, multiple sclerosis and glioma (8-11) due to its role in the regulation of levels of critical biologically active downstream KP metabolites (3). Polymorphisms in the TDO2 gene have been implicated for a role in behavioural responses and autism (12,13).

References

  1. Lewis-Ballester, A. et al. (2016) Sci. Rep. 6:35169.
  2. Rafice, S.A. et al. (2009) Biochem. Soc. Trans. 37:408.
  3. Badawy, A. (2017) Int J. Tryptophan Res. 10:1.
  4. Pilotte, L. et al. (2012) Proc. Natl. Acad. Sci. U.S.A. 109:2497.
  5. D'Amato, N.C. et al. (2015) Cancer Res. 75:4651.
  6. Yu, C.P et al. (2017) Med. Oncol. 34:73.
  7. Platten, et al. (2015) Front. Immunol. 5:673.
  8. Breda, C. et al. (2016) Proc. Natl. Acad. Sci. U.S.A. 113:5435
  9. Yu, C.P. et al. (2016) Metab. Brain Dis. 31:737.
  10. Lanz. T.V. et al. (2017) Sci. Rep. 7:41271.
  11. Reus, G.Z. et al. (2018) Prog. Neuropsychopharmacol. Biol. Psychiatry 81:55.
  12. Soichot, M. et al. (2013) Alcohol Alcohol 48:415.
  13. Nabi, R. et al. (2004) Am. J. Med. Genet. B. Neuropsychiatr. Genet. 125B:63.

Long Name

Tryptophan 2,3-dioxygenase

Alternate Names

chky, TDO, TO, TRPO, Tryptophan Oxygenase, Tryptophan Pyrrolase, Tryptophanase

Entrez Gene IDs

6999 (Human); 56720 (Mouse); 64206 (Rat)

Gene Symbol

TDO2

UniProt

P48776

Additional TDO2 Products

Product Documents for Recombinant Mouse TDO2 His-tag Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Mouse TDO2 His-tag Protein, CF

For research use only

Customer Reviews for Recombinant Mouse TDO2 His-tag Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Mouse TDO2 His-tag Protein, CF and earn rewards!

Have you used Recombinant Mouse TDO2 His-tag Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Mouse TDO2 His-tag Protein, CF (10001-TD):

Materials
  • Assay Buffer: 50 mM MES, pH 6.5
  • 0.405 M Tris, pH 8.0
  • Recombinant Mouse TDO2 (rmTDO2) (Catalog # 10001-TD)
  • Ascorbic Acid (Sigma, Catalog # 255564), 500 mM stock in deionized water
  • L-Tryptophan (Sigma, Catalog # T0254), 40 mM stock in deionized water
  • Catalase (Sigma, Catalog # C30), 100,000 Units/mL stock in Assay Buffer
  • Methylene Blue (Sigma, Catalog # 28514), 10 mM stock in deionized water
  • 96-well Clear Plate (Catalog # DY990)
  • Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent
  1. Prepare Substrate Mixtures.
     a.  Dilute L-Tryptophan to 8 mM in Assay Buffer
     b.  Dilute Ascorbic acid to 80 mM in 0.405 M Tris, pH 8.0.
     c.  Prepare a mixture of 9000 Units/mL catalase, and 40 µM Methylene Blue in Assay Buffer.
     d.  Mix equal volumes of 1b and 1c for final concentrations of 40 mM Ascorbic Acid, 4500 units/mL Catalase, and  20 µM Methylene Blue.
  2. Dilute rmTDO2 to 40 ng/µL in Assay Buffer.
  3. Load 25 µL of 40 ng/µL rmTDO2 to clear plate, and start the reaction by adding 25 µL of 8 mM L-Tryptophan followed by 50 µL of Mixture 1d.  Include a Substrate Blank containing 25 µL Assay Buffer, 25 µL 8 mM L-Tryptophan and 50 µL of Mixture 1d.
  4. Read plate in kinetic mode for 5 minutes at an absorbance of 321 nm.
  5. Calculate specific activity:
     

     Specific Activity (pmol/min/µg) =

Adjusted Vmax* (OD/min) x well volume (L) x 1012 pmol/mol
ext. coeff** (M-1cm-1) x path corr.*** (cm) x amount of enzyme (µg)

  *Adjusted for Substrate Blank.
**Using the extinction coefficient 3750 M-1cm-1.
***Using the path correction 0.32 cm.
Note: the output of many spectrophotometers is in mOD. Per Well:

  • rmTDO2: 1.0 µg
  • Ascorbic Acid: 20 mM
  • L-Tryptophan: 2 mM
  • Catalase: 225 units
  • Methylene Blue: 10 µM

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes